Please confirm your location

Primary Sidebar

Pipeline
bemcentinib | NSCLC
bemcentinib | COVID-19
bemcentinib | Melanoma
bemcentinib | AML
BGB149
BGB601
Discovery
Publications
Expanded access policy

News Subscription

Please remember to confirm your email by clicking on the link provided in the subscription confirmation email.

We will save your name and email address with the sole purpose of sending information regarding our latest news and events. By subscribing to BerGenBio’s newsletter you consent to our Privacy Policy and Terms of Use.

Footer

Key Information

Pipeline
Investors
News
Presentations
Management Team

Useful Information

Privacy Policy
Terms of Use
Job Applicant Privacy Notice
Site Map

Get In Touch

BerGenBio ASA
Company registration number 992 219 688

Jonas Lies vei 91, 5009 Bergen, Norway

www.bergenbio.com

+ 47 559 61 159